Connection

AMY MCGUIRE to Sequence Analysis, DNA

This is a "connection" page, showing publications AMY MCGUIRE has written about Sequence Analysis, DNA.
Connection Strength

2.330
  1. Clinical integration of next generation sequencing: a policy analysis. J Law Med Ethics. 2014; 42 Suppl 1:5-8.
    View in: PubMed
    Score: 0.290
  2. The indispensable role of professional judgment in genomic medicine. JAMA. 2013 Apr 10; 309(14):1465-6.
    View in: PubMed
    Score: 0.276
  3. Personal genome research : what should the participant be told? Trends Genet. 2010 May; 26(5):199-201.
    View in: PubMed
    Score: 0.224
  4. Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet. 2008 02; 9(2):152-6.
    View in: PubMed
    Score: 0.192
  5. Genetics. No longer de-identified. Science. 2006 Apr 21; 312(5772):370-1.
    View in: PubMed
    Score: 0.170
  6. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet. 2019 01 03; 104(1):76-93.
    View in: PubMed
    Score: 0.103
  7. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2).
    View in: PubMed
    Score: 0.090
  8. Developing context-specific next-generation sequencing policy. Nat Biotechnol. 2016 05 06; 34(5):466-70.
    View in: PubMed
    Score: 0.085
  9. Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing. J Empir Res Hum Res Ethics. 2016 02; 11(1):21-30.
    View in: PubMed
    Score: 0.084
  10. Potential Psychosocial Risks of Sequencing Newborns. Pediatrics. 2016 Jan; 137 Suppl 1:S24-9.
    View in: PubMed
    Score: 0.083
  11. Are physicians prepared for whole genome sequencing? a qualitative analysis. Clin Genet. 2016 Feb; 89(2):228-34.
    View in: PubMed
    Score: 0.080
  12. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials. 2014 Mar 20; 15:85.
    View in: PubMed
    Score: 0.074
  13. Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group. Genet Med. 2014 Oct; 16(10):727-35.
    View in: PubMed
    Score: 0.073
  14. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol. 2013 Nov; 11(11):e1001699.
    View in: PubMed
    Score: 0.072
  15. Adult genetic risk screening. Annu Rev Med. 2014; 65:1-17.
    View in: PubMed
    Score: 0.072
  16. Personalized genomic disease risk of volunteers. Proc Natl Acad Sci U S A. 2013 Oct 15; 110(42):16957-62.
    View in: PubMed
    Score: 0.071
  17. Policy uncertainty, sequencing, and cell lines. G3 (Bethesda). 2013 Aug 07; 3(8):1205-7.
    View in: PubMed
    Score: 0.070
  18. Point-counterpoint. Ethics and genomic incidental findings. Science. 2013 May 31; 340(6136):1047-8.
    View in: PubMed
    Score: 0.069
  19. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med. 2012 Apr; 14(4):405-10.
    View in: PubMed
    Score: 0.064
  20. The complete genome of an individual by massively parallel DNA sequencing. Nature. 2008 Apr 17; 452(7189):872-6.
    View in: PubMed
    Score: 0.049
  21. Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019 03; 21(3):622-630.
    View in: PubMed
    Score: 0.025
  22. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med. 2010 Apr 01; 362(13):1181-91.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.